614 news items
Page 13 of 31
oaiwxkg6c877 wkmcevg2tqu2k3y2sec347g
GILD
14 May 24
with complex and hard-to-treat blood cancers."
Kite and its multiple myeloma (MM) partner Arcellx
m80caefk65eyflfk1v2bf5onaw1boy8h8tf65v0
FBIO
14 May 24
patient was dosed in a multi-center, placebo-controlled, randomized Phase 2 study of Triplex, a vaccine for control of cytomegalovirus ("CMV
fx1c5v
IQV
14 May 24
for medicines grew 2.5% in 2023, reaching $435Bn at net price level, reflecting a sharp decline in COVID-19 vaccines and therapeutics
fobkcrc6n
IOBT
14 May 24
-D18) of lead investigational therapeutic cancer vaccine, IO102-IO103, in combination with pembrolizumab still expected in Q3 2024; outcome of primary
3hpc3oxhfjhzzplyyx31fwtn011hd m2t5ritfizdmu22ck5op821ay
CRDL
14 May 24
infection and commonly used drugs and mRNA vaccines, as well as therapies used to treat several common cancers, including chemo-therapeutic agents
iavrjjx27om6w3m32 dzeyqnc7
14 May 24
-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, announces today that Neil
2qahlcxew31
14 May 24
undergoing chemoradiotherapy. VB10.16 is a potentially first-in-class off-the-shelf therapeutic cancer vaccine specifically
isj7disajrg9 4ilbdnwojmpj
14 May 24
of head and neck cancer and cervical cancer. VB10.NEO, an individualized cancer neoantigen vaccine, is exclusively out-licensed to Genentech, a member
ui1lvcf9zr c4vwnpb8ynkohklhcuuhjmi9a2mkejlz
TNXP
13 May 24
, is an approximately 45,000 square foot BSL-2 facility intended for clinical scale manufacturing of live-virus vaccines and biologics
dobtklqsoowg38x2dfvvn8mg4opkdr 95pb3vxup1qj
LLY
PFE
13 May 24
to build on the success of its COVID-19 vaccine rollout by introducing a direct-to-consumer
61tyyhhcbqn7jl4cdgg7e809 z7lo2aqw
13 May 24
(including malaria, HIV/AIDS and tuberculosis) – and on novel therapeutic vaccines against cancer, including personalized cancer vaccines
jrmy5m4pqlowtvn38ukg5a9artiyxjhdhx2t0uxhrlo fkqf3
13 May 24
Size By Method (Viral Removal, Viral Inactivation), By Application (Recombinant Proteins, Blood And Blood Products, Vaccines), By End-User
ok5pzkd6gsmfth90v5qh7bwaafue7l59dr8xcedjuap3im
13 May 24
.Cancer. For children and adults taking TNF blockers, including Adalimumab-adbm, the chances
k0sqoyoa38fe 1bh4m2f4zwoug9e1dsrmq
13 May 24
RNA technology, offering a new and novel format for researchers working in applications such as vaccine, cancer immunotherapy, and gene or cell
gg5f1gfkfn8fulphmxl7qvyfbku
MRK
13 May 24
and combinations that build on the foundation of KEYTRUDA, with a goal to improve upon current standards of care and help even more patients with cancer
41t36cs76blypmkgibrrm5vy21gnnt1r9bqfe89wrv2k10ml8sqd3utru
REGN
13 May 24
a parasitic (helminth) infection.are scheduled to receive any vaccinations. You should not receive a "live vaccine" right before and during
zy6osis gox3lkeifaeo4ya00sspnhrna40eyyro9p32mca
11 May 24
Positive data from Phase 1 trial of RBI-4000 vaccine
rm661 7gcsuh26krj2h3757nyrkzn86wc2dbcb
BVAXF
10 May 24
Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using
3a5kuji7texq7edwy74ga23dqq0glejb18zxracnmv
EVAX
10 May 24
" or the "Company"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced that on May 7, 2024
x1f3ojnb0j kz5tmc5wv
10 May 24
protection measures. help protect us from skin cancer and early skin aging caused by the sun. The FDA continues to evaluate sunscreen products to ensure